Santen Oy
7 products tracked · names used in filings: Santen Oy
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Opsiria sirolimus | Application withdrawn | |
| 🇪🇺 | Ryjunea atropine sulfate | Authorised | 2025-06-02 |
| 🇪🇺 | Catiolanze latanoprost | Authorised | 2023-11-15 |
| 🇪🇺 | Roclanda latanoprost / netarsudil | Authorised | 2021-01-07 |
| 🇪🇺 | Rhokiinsa netarsudil | Authorised | 2019-11-19 |
| 🇪🇺 | Verkazia ciclosporin | Authorised | 2018-07-06 |
| 🇪🇺 | Ikervis ciclosporin | Authorised | 2015-03-19 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.